Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

59.58 -1.70 (-2.77%)
Delayed Quote Updated: 11:34 AM EST, Nov 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
From AtriCure, Inc.
Via Business Wire
News headline image
Navigating 6 Analyst Ratings For AtriCure ↗
 
Via Benzinga
News headline image
Analyst Ratings For AtriCure ↗
 
Via Benzinga
News headline image
Cracking The Code: Understanding Analyst Reviews For AtriCure ↗
 
Via Benzinga
News headline image
Key Takeaways From AtriCure Analyst Ratings ↗
 
Via Benzinga
News headline image
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024 ↗
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
AtriCure Reports Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
From AtriCure, Inc.
Via Business Wire
News headline image
Cracking The Code: Understanding Analyst Reviews For AtriCure ↗
 
Via Benzinga
News headline image
Recap: AtriCure Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 15, 2024 ↗
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
Via Benzinga
News headline image
AtriCure's Earnings: A Preview ↗
 
Via Benzinga
News headline image
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025 ↗
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From AtriCure, Inc.
Via Business Wire
News headline image
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024 ↗
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
AtriCure Reports First Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
News headline image
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
From AtriCure, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Appoints Shlomi Nachman to the Board of Directors
From AtriCure, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.